Screening en diagnostics

In the ‘screening and diagnostics’ development area we are busy fine-tuning and innovating the set of instruments used for screening and diagnostics within the psychotraumatology domain in order to ultimately arrive at a predictive diagnostics as well as (inter)national standards.

Scope and aims of the development area ‘screening and diagnostics’:

What this involves ranges from a timely use of psycho-educational instruments to an optimization of highly specialized 3rd-line diagnostics, to their use in patient platforms, web portals and apps but also to the development of the most appropriate form of effect measurement. The development area covers all organizations in ARQ National Psychotrauma Center as well as external organizations engaged in the screening and diagnostics of psychotrauma in the zeroth, 1st, 2nd and 3rd lines.

Relationship between the sub-projects:

Common goal of the sub-projects within this development area is to arrive at a modular set of diagnostic tools for psychotrauma, with instruments (modules) geared to different development stages (indicating severity) of the psychotrauma problems and the various target groups/domains (patient profiles). The development area will also be extended to include instruments that can predict the course of complaints or reactions to treatment within a particular development stage or target group. The adoption of such a ‘staging’ and ‘profiling’ approach in the further development of psychotrauma diagnostics will bring everyday practices closer to a step-by-step kind of diagnostics, which in turn dovetails with the ‘stepped-care principle’ (as ‘light’ as possible and as ‘intensive' as necessary). And, it also takes into account the ‘matched-care principle’ (fine-tuning dosages and proceeding by patient variables).

Actual end products:

  • The sets of instruments for screening and diagnostics as used in ARQ are better aligned and are comprised within one step-by-step (modular) set of diagnostics instruments for psychotrauma covering the entire care chain (from zeroth to 3rd line).
  • Partners in ARQ make use of this set of screening and diagnostics instruments by means of the same (modular) medium: ‘Compass 2.0’.
  • Data collection is safeguarded within the primary process, data are collected within one database and links with other data files have been established.
  • Diagnostics and Compass 2.0 are further developed in consultation and coproduction with and for other national (and international) players in the field of mental healthcare and psychotrauma to achieve national (and international) standards through the Network Psychotrauma NL (NPN).

Desired benefits:

The diagnostic applications to be developed can be used and implemented within ARQ and the wider psychotrauma care chains in the Netherlands. This will improve communication between the joint partners in ARQ as well as external communication, facilitate client referrals, and make the screening and diagnostics of psychotrauma more efficient.

Also, research data will be of a better quality, and a cycle of further developments as to the diagnostic tools for psychotrauma will be enabled. Data thus collected will lead to new insights, underpin scientific research in the field of psychotraumatology and ultimately yield treatment predictors.
Moreover, the efforts expended as part of this development area will result in a more step-by-step kind of diagnostic instruments for psychotrauma used throughout the country and supported internationally, which in turn will lead to ARQ’s stronger positioning as a psychotrauma expert.